Champions Oncology, Inc. CSBR
4.85 USD +0.02 (+0.41%)
Nov 5, 2026, 10:37 AM EST
4.72 Day range 4.85
4.59 52-week range 8.31
- YTD
- -29.81%
- 1 year
- -28.68%
Revenue & Expenses
Latest period ending Apr 30, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Apr 30, 2026 | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 |
|---|---|---|---|---|---|
| 59.42M | 56.94M | 50.16M | 53.87M | 49.11M | |
| 28.52M | 28.55M | 20.75M | 24.34M | 25.48M | |
| -1.14M | 4.55M | -7.36M | -5.26M | 607.00K | |
| -1.18M | 4.70M | -7.28M | -5.33M | 548.00K | |
| -0.08 | 0.33 | -0.54 | -0.39 | 0.04 |
Balance sheet
| Fiscal year | FY 2026 Apr 30, 2026 | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 |
|---|---|---|---|---|---|
| 4.87M | 9.79M | 2.62M | 10.12M | 9.01M | |
| 26.99M | 32.34M | 26.13M | 34.31M | 35.38M | |
| 22.92M | 28.57M | 28.04M | 29.68M | 26.28M | |
| 4.51M | 6.11M | 7.43M | 8.60M | 9.47M | |
| 3.94M | 3.77M | -1.90M | 4.64M | 9.10M |
Cash flow
| Fiscal year | FY 2026 Apr 30, 2026 | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 |
|---|---|---|---|---|---|
| -4.47M | 7.39M | -6.14M | 3.97M | 6.50M | |
| -540.00K | -389.00K | -836.00K | -2.87M | -2.38M | |
| 99.00K | 170.00K | -527.00K | 11.00K | 207.00K | |
| -540.00K | -389.00K | -836.00K | -2.87M | -2.38M | |
| -4.91M | 7.17M | -7.50M | 1.11M | 4.32M |